Estrogen receptor beta--a new dimension in estrogen mechanism of action
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The cloning of estrogen receptor (ER ) has provided the first example of a steroid hormone receptor existing as two isoforms, each of which is encoded by a separate gene (Kuiper et al. 1996). The finding of ER was met with great surprise, as the existence of more than one estrogen receptor had been actively denied for several decades. Attempts to clone a second estrogen receptor on the basis of sequence homology to the classical estrogen receptor (ER ) were not successful, although this approach did lead to the identification of two orphan receptors, namely estrogen receptor-related receptors (ERR) 1 and 2 (Giguere et al. 1988). However, none of these ER-related orphan receptors binds estrogens and it is still unclear whether they require specific ligands in order to be activated. ER seems to be a most important factor in the mechanism of action of estrogen, and it is expressed in many tissues, including the central nervous system, the cardiovascular system, the immune system, the urogenital tract, the gastrointestinal tract, the kidneys and the lungs (Arts et al. 1997, Enmark et al. 1997, Kuiper et al. 1997, 1998a, c, Lindner et al. 1998, O} sterlund et al. 1998). Although ER is also expressed in the mammary gland, it appears that ER is an important estrogen receptor in this particular tissue, and in the uterus also there seems to be much more ER present than ER (Fig. 1). This dominant role of ER in the uterus probably explains why it was the first cloned estrogen receptor, as most purification and cloning attempts were based on uterine tissue. As will be referred to below, it is now obvious that ER plays an important role in the physiology of several tissues, and it cannot be excluded that it is the more generally expressed estrogen receptor, whereas ER dominates in some few specific tissues and is mainly involved in reproductive events. Obviously, these differences in tissue distribution are of extreme importance from the pharmaceutical point of view, as hormone replacement therapy in postmenopausal women is such an increasingly significant health issue. Although the DNA-binding domains of ER and ER show a high degree of homology (only three amino acids differ), the ligand-binding domain shows only 59% homology (Fig. 2). Closer inspection indicates that it should be possible to develop ER and ER -specific ligands. In view of the facts presented above, it is not unreasonable to assume that it might be possible to develop ER -specific estrogen agonists targeting the central nervous system, the urogenital tract, the cardiovascular system and bone, but leaving the mammary gland and uterus relatively unaffected. In this way, much of the current controversy concerning estrogen treatment of postmenopausal women might be resolved (Barkhem et al. 1998, Gustafsson 1998a,b, Kuiper et al. 1998b, Nilsson et al. 1998).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Self-citationInteraction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203
Self-citationGeneration and reproductive phenotypes of mice lacking estrogen receptor β
Krege, J. H., Hodgin, J. B., Couse, J. F., Enmark, E., Warner, M., Mahler, J. F., Sar, M., Korach, K. S., Gustafsson, J.-Å., & Smithies, O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15677 · Cited by 1,691
Self-citationIdentification of a new class of steroid hormone receptors
Giguère, V., Yang, N., Segui, P., & Evans, R. M. (1988) · Nature · doi:10.1038/331091a0 · Cited by 867
Barkhem, T., Carlsson, B., Nilsson, Y., Enmark, E., Gustafsson, J.-Å., & Nilsson, S. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.105 · Cited by 779
Self-citationEstrogen inhibits the vascular injury response in estrogen receptor α-deficient mice
Iafrati, M. D., Karas, R. H., Aronovitz, M., Kim, S., Sullivan, T. R., Lubahn, D. B., O'Donnell, T. F., Korach, K. S., & Mendelsohn, M. E. (1997) · Nature Medicine · doi:10.1038/nm0597-545 · Cited by 486
Österlund, M., G.J.M. Kuiper, G., Gustafsson, J.-Å., & Hurd, Y. L. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00351-3 · Cited by 379
Self-citationIncreased Expression of Estrogen Receptor-β mRNA in Male Blood Vessels After Vascular Injury
Lindner, V., Kim, S. K., Karas, R. H., Kuiper, G. G. J. M., Gustafsson, J.-A., & Mendelsohn, M. E. (1998) · Circulation Research · doi:10.1161/01.res.83.2.224 · Cited by 294
Self-citationSaunders, P., Fisher, J., Sharpe, R., & Millar, M. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.156r013 · Cited by 268
Hess, R. A., Gist, D. H., Bunick, D., Lubahn, D. B., Farrell, A., Bahr, J. M., Cooke, P. S., & Greene, G. L. (1997) · PubMed · Cited by 268
Cited by
Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
Riggs, B. L., & Hartmann, L. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022219 · Cited by 968
Interaction of Phytoestrogens with Estrogen Receptors .ALPHA. and .BETA..
MORITO, K., HIROSE, T., KINJO, J., HIRAKAWA, T., OKAWA, M., NOHARA, T., OGAWA, S., INOUE, S., MURAMATSU, M., & MASAMUNE, Y. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.351 · Cited by 614
Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse
Hara, Y., Waters, E. M., McEwen, B. S., & Morrison, J. H. (2015) · Physiological Reviews · doi:10.1152/physrev.00036.2014 · Cited by 470
Interaction of Phytoestrogens with Estrogen Receptors .ALPHA. and .BETA.(II).
Morito, K., Aomori, T., Hirose, T., Kinjo, J., Hasegawa, J., Ogawa, S., Inoue, S., Muramatsu, M., & Masamune, Y. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.48 · Cited by 464
Liu, J., Burdette, J. E., Xu, H., Gu, C., van Breemen, R. B., Bhat, K. P. L., Booth, N., Constantinou, A. I., Pezzuto, J. M., Fong, H. H. S., et al. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0014157 · Cited by 428
Leav, I., Lau, K.-M., Adams, J. Y., McNeal, J. E., Taplin, M.-E., Wang, J., Singh, H., & Ho, S.-M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61676-8 · Cited by 394
ERβ Inhibits Proliferation and Invasion of Breast Cancer Cells
Lazennec, G., Bresson, D., Lucas, A., Chauveau, C., & Vignon, F. (2001) · Endocrinology · doi:10.1210/endo.142.9.8395 · Cited by 380
Platet, N., Cathiard, A. M., Gleizes, M., & Garcia, M. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.02.001 · Cited by 367
Phytoestrogens and breast cancer
Adlercreutz, H. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00273-x · Cited by 322
The biological role of estrogen receptors α and β in cancer
Pearce, S. T., & Jordan, V. C. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.003 · Cited by 311
Molecular Mechanisms of Selective Estrogen Receptor Modulator (SERM) Action
Dutertre, M., & Smith, C. L. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38923-2 · Cited by 299
Molecular Mechanisms in Spermatogenesis
(2008) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-09597-4 · Cited by 276
Costa, C., Soares, R., Reis-Filho, J. S., Leitao, D., Amendoeira, I., & Schmitt, F. C. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.6.429 · Cited by 275
Thornton, M. J. (2013) · Dermato-Endocrinology · doi:10.4161/derm.23872 · Cited by 270
Harris, D. M., Besselink, E., Henning, S. M., Go, V. L. W., & Heber, D. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523000807 · Cited by 231
From pregnancy to preeclampsia: a key role for estrogens
Berkane, N., Liere, P., Oudinet, J.-P., Hertig, A., Lefèvre, G., Pluchino, N., Schumacher, M., & Chabbert-Buffet, N. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1065 · Cited by 223
Vasudevan, N., Ogawa, S., & Pfaff, D. (2002) · Physiological Reviews · doi:10.1152/physrev.00014.2002 · Cited by 129
Jiang, J., Wu, S., Wang, Y., An, X., Cai, L., Zhao, X., & Wu, C. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.06.003 · Cited by 93
Concentrated ambient PM2.5exposure affects mice sperm quality and testosterone biosynthesis
Yang, Y., Yang, T., Liu, S., Cao, Z., Zhao, Y., Su, X., Liao, Z., Teng, X., & Hua, J. (2019) · PeerJ · doi:10.7717/peerj.8109 · Cited by 58
Bazedoxifene for the prevention of postmenopausal osteoporosis
Gennari, L. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3476 · Cited by 39
“While both the ERs bind estrogen as well as other agonists or antagonists (even though with different affi nities), they have distinctly different localizations and concentrations in several tissues, including bone (Gustafsson 1999; Bord et al 2001).”
Metadata
- Authors
- Gustafsson, J.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 1999-12-01
- Volume
- 163
- Issue
- 3
- Pages
- 379-383
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2064482843
- Cited by
- 423
- References
- 18
- FWCI
- 14.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.